We all want a flawless, bright-eyed, smooth, clear face. But whether it’s spots, dry skin, flushed cheeks or cracked lips, we ...

Ascletis Pharma has reported positive topline Phase III results showing that denifanstat (ASC40), a first-in-class oral FASN inhibitor for moderate-to-severe acne, delivered a favorable long-term ...

HONG KONG, Jan. 29, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announced positive topline results from the Phase III open-label study (NCT06248008) evaluating denifanstat ...

If you’re someone who’s experienced recurring bouts of cystic acne, you’ll know there’s no one-size-fits-all approach to keeping acne flares at bay. Clearing your skin can feel like a bit of a waiting ...

PARIS — Oral treatment with the novel fatty acid synthase inhibitor denifanstat was associated with significant improvements in moderate-to-severe acne in a phase 3 trial presented at the European ...

Step into your local drugstore and you’ll come across countless cleansers, serums, lotions and masks all promising the same thing: fewer acne breakouts and clearer, smoother skin. Unfortunately, not ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

Say goodbye to breakouts! Try these 8 face washes for acne-prone skin to clear pimples and control excess oil.| Lifestyle ...